BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
158 results:

  • 1. Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of colorectal cancer.
    Emiloju OE; Storandt M; Zemla T; Tran N; Jethwa K; Mahipal A; Mitchell J; Thiels C; Mathis K; McWilliams R; Hubbard J; Sinicrope F; Shi Q; Jin Z
    JCO Precis Oncol; 2024 Jan; 8():e2300127. PubMed ID: 38237099
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Time trends of 16 modifiable risk factors on the burden of major cancers among the Chinese population.
    Li J; Song X; Ni Y; Zhu S; Chen W; Zhao Y; Yi J; Xia L; Nie S; Shang Q; Liu L
    Int J Cancer; 2024 Apr; 154(8):1443-1454. PubMed ID: 38126210
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Short-term and long-term outcomes of intracorporeal anastomosis in laparoscopic segmental left colectomy for splenic flexure cancer - a multicenter retrospective cohort study of 342 cases.
    Zhang M; Dong S; Wang L; Liu Z; Zhou H; Liu Q; Chen Y; Tang J; Wang X
    Int J Surg; 2024 Mar; 110(3):1595-1604. PubMed ID: 38085798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Risk of cancer in acromegaly patients: An updated meta-analysis and systematic review.
    Xiao Z; Xiao P; Wang Y; Fang C; Li Y
    PLoS One; 2023; 18(11):e0285335. PubMed ID: 38032888
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. COLD SNARE POLYPECTOMY: A SAFE PROCEDURE FOR REMOVING SMALL NON-PEDUNCULATED colorectal LESIONS.
    Santos CEOD; Malaman D; Sanmartin IDA; Leão ABS; Bombassaro IZ; Pereira-Lima JC
    Arq Gastroenterol; 2023; 60(4):470-477. PubMed ID: 38018552
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Outcomes of transanal total mesorectal excision compared to laparoscopic total mesorectal excision: A meta-analysis of randomized controlled trials.
    Emile SH; Wignakumar A; Horesh N; Garoufalia Z; Rogers P; Zhou P; Strassmann V; Wexner SD
    Surgery; 2024 Feb; 175(2):289-296. PubMed ID: 38001011
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Establishment and Validation of a Postoperative VTE Prediction Model in Patients with colorectal cancer Undergoing Radical Resection: CRSPOT Nomogram.
    Wu Y; Wang L; Yin Q; Deng L; Ma J; Tian X
    Clin Appl Thromb Hemost; 2023; 29():10760296231216966. PubMed ID: 37997283
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Secondary Primary cancer Risk After Radiation Therapy in Rectal cancer: A Population-Based Cohort Study With Propensity Score Matching.
    Schlesinger-Raab A; Schubert-Fritschle G; Kim M; Werner J; Belka C; Wolff H; Agha A; Fuchs M; Friess H; Combs S; Häussler B; Engel J; Halfter K
    Clin Colorectal Cancer; 2023 Dec; 22(4):485-495.e3. PubMed ID: 37838522
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
    Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
    J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of Tumor-Stroma Ratio (TSR) in Predicting Outcomes of Malignant Tumors.
    Pyo JS; Kim NY; Min KW; Kang DW
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512068
    [No Abstract]    [Full Text] [Related]  

  • 11. Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal cancer in the CRONOS Study.
    Guzmán Y; Ríos J; Paredes J; Domínguez P; Maurel J; González-Abós C; Otero-Piñeiro A; Almenara R; Ladra M; Prada B; Pascual M; Guerrero MA; García-Granero Á; Fernández L; Ochogavia-Seguí A; Gamundi-Cuesta M; González-Argente FX; Pons LV; Centeno A; Arrayás Á; de Miguel A; Gil-Gómez E; Gómez B; Martínez JG; Lacy AM; de Lacy FB
    JAMA Surg; 2023 Sep; 158(9):910-919. PubMed ID: 37436726
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Anijs RJS; Chen Q; van der Hulle T; Versteeg HH; Klok FA; Lijfering WM; Cannegieter SC
    Thromb Res; 2023 Sep; 229():90-98. PubMed ID: 37421683
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Functional Analysis and Clinical Importance of atp1a1 in Colon cancer.
    Sumiyoshi S; Shiozaki A; Kosuga T; Simizu H; Kudo M; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Kubota T; Fujiwara H; Morinaga Y; Konishi E; Otsuji E
    Ann Surg Oncol; 2023 Oct; 30(11):6898-6910. PubMed ID: 37407874
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted and functional genomics approaches to the mechanism of action of lagunamide D, a mitochondrial cytotoxin from marine cyanobacteria.
    Luo D; Ratnayake R; Atanasova KR; Paul VJ; Luesch H
    Biochem Pharmacol; 2023 Jul; 213():115608. PubMed ID: 37201874
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparative short-term and survival outcomes of three specimen extraction techniques in laparoscopic low rectal cancer surgery: does it affect ileostomy closure?
    Chen H; Huang F; Yang M; Zhao Z; Guan X; Liu Z; Jiang Z; Liu Q; Zheng Z; Wang X
    BMC Surg; 2023 May; 23(1):122. PubMed ID: 37170142
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrating a tumour appropriate transanal or robotic assisted approach to total mesorectal excision in high-volume rectal cancer practice is safe and cost-effective.
    Fleming C; Fernandez B; Boissieras L; Cauvin T; Denost Q
    J Robot Surg; 2023 Oct; 17(5):1979-1987. PubMed ID: 37099264
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Magnifying chromoendoscopy is a reliable method in the selection of rectal neoplasms for local excision.
    Kimura CMS; Kawaguti FS; Horvat N; Nahas CSR; Marques CFS; Pinto RA; de Rezende DT; Segatelli V; Safatle-Ribeiro AV; Junior UR; Maluf-Filho F; Nahas SC
    Tech Coloproctol; 2023 Nov; 27(11):1047-1056. PubMed ID: 36906661
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
    Nso N; Nyabera A; Nassar M; Mbome Y; Emmanuel K; Alshamam M; Sumbly V; Guzman L; Shaukat T; Bhangal R; Ojong GA; Radparvar F; Rizzo V; Munira MS
    PLoS One; 2023; 18(1):e0262013. PubMed ID: 36706093
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treatment and Survival Outcomes for Patients with colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Dietz MV; Ziekman MJ; van Kooten JP; Brandt-Kerkhof ARM; van Meerten E; Verhoef C; Madsen EVE
    Ann Surg Oncol; 2023 Apr; 30(4):2048-2056. PubMed ID: 36566258
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. How Far Is Too Far? Cost-Effectiveness Analysis of Regionalized Rectal cancer Surgery.
    Leeds IL; Xu Z; Loria A; Pantel HJ; Mongiu AK; Longo WL; Reddy V
    Dis Colon Rectum; 2023 Mar; 66(3):467-476. PubMed ID: 36538713
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.